CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) as a Resource
CNS HIV 抗逆转录病毒治疗效果研究 (CHARTER) 作为资源
基本信息
- 批准号:8891275
- 负责人:
- 金额:$ 33.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-16 至 2015-09-15
- 项目状态:已结题
- 来源:
- 关键词:AIDS neuropathyAnti-Retroviral AgentsBackBrain imagingCaliforniaClinical ResearchCollaborationsCommunitiesComplementDataData SetDatabasesDictionaryDiseaseDrug abuseFeedbackFosteringFundingGeneticHIVHighly Active Antiretroviral TherapyImageIndividualMedicalMorbidity - disease rateNeurocognitiveNeurologicNeuropathyParticipantPeripheral Nervous System DiseasesProceduresProcessProtocols documentationResearchResearch PersonnelResearch Project GrantsResourcesSamplingSystemTexasUniversitiesViralVisitWashingtonantiretroviral therapybasecatalystmedical schoolsmortalityneuropsychologicalperformance sitequality assurance
项目摘要
The CNS HIV Antiretroviral Therapy Effects Research (CHARTER) was funded in 2002 with the aim of exploring the changing presentation of HIV neurological complications in the context of Highly Active Antiretroviral Therapy (HAART). The six performance sites of CHARTER (Johns Hopkins University, Mt. Sinai Medical School, University of California at San Diego, University of Texas Medical Branch at Galveston, University of Washington, Washington University at St. Louis), were able to standardize neuromedical, neuropsychological, psychiatric, neuropathy, and imaging protocols along with on-going quality assurance procedures. Two key conclusions to emerge from the CHARTER project are that HIV-Associated Neurocognitive Disorders (HAND) and peripheral neuropathy remain highly prevalent despite effective HIV treatments that have significantly reduced mortality and non-neurologic morbidities. The CHARTER project has accumulated invaluable clinical and research data with longitudinal data being collected on 674 participants. Data includes neuromedical characterization, neuropsychological functioning, psychiatric and drug abuse variables, treatment data, brain imaging, and viral and host genetics information. Each CHARTER visit generates approximately 4000 individual variables; currently the database contains over 5 million data points. A key component of the CHARTER project is to serve as a catalyst for additional studies and analyses by making this wealth of samples and data available to investigators. In order to continue to make samples and data sets available to the NeuroAIDS community, ¿CHARTER as a Resource¿ will be enhanced with the following; 1) CHARTER Imaging Utilities; 2) Document Collaboration Utilities to facilitate cross institutional collaboration (e.g., check-in/check-out systems, change tracking and automated document back-ups); 3) User Management Enhancements (e.g., access to warehoused data and community based utilities to foster cross institutional collaboration); and 4) Data Dictionary Enhancements. In addition, CHARTER as a Resource will solicit feedback from users to further enhance the Resource utilities. These enhancements will complement carefully constructed and established mechanisms for a) announcing the availability of the resource, b) soliciting requests, c) facilitating scientific review of all requests, and d) processing and distributing samples and data to scientific requestors.
CNS HIV抗逆转录病毒治疗效果研究(CHARTER)于2002年获得资助,目的是探索在高效抗逆转录病毒治疗(HAART)背景下HIV神经系统并发症的变化。查特的六个表演场地(约翰霍普金斯大学,山。Sinai医学院、加州大学圣地亚哥分校、德克萨斯大学医学分支加尔维斯顿分校、华盛顿大学、华盛顿大学圣路易斯分校)能够标准化神经医学、神经心理学、精神病学、神经病和成像方案沿着持续的质量保证程序。CHARTER项目得出的两个关键结论是,尽管有效的HIV治疗显著降低了死亡率和非神经系统疾病,但HIV相关神经认知障碍(HAND)和周围神经病变仍然非常普遍。CHARTER项目积累了宝贵的临床和研究数据,收集了674名参与者的纵向数据。数据包括神经医学表征,神经心理功能,精神和药物滥用变量,治疗数据,脑成像,病毒和宿主遗传学信息。每次访问CHARTER都会产生大约4000个独立变量;目前数据库包含超过500万个数据点。CHARTER项目的一个关键组成部分是通过向调查人员提供这一丰富的样本和数据,促进更多的研究和分析。为了继续向NeuroAIDS社区提供样本和数据集,CHARTER作为资源将通过以下内容进行增强:1)CHARTER成像实用程序; 2)文档协作实用程序,以促进跨机构协作(例如,签入/签出系统、更改跟踪和自动化文档备份); 3)用户管理增强(例如,访问仓库数据和基于社区的实用程序,以促进跨机构协作);以及4)数据字典增强。此外,CHARTER作为一种资源将征求用户的反馈意见,以进一步加强资源实用程序。这些改进将补充精心构建和建立的机制,用于a)宣布资源的可用性,B)征求请求,c)促进对所有请求的科学审查,以及d)处理和向科学请求者分发样本和数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IGOR GRANT其他文献
IGOR GRANT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IGOR GRANT', 18)}}的其他基金
Obstructive Sleep Apnea Endotypes and Impact on Phenotypes of People Living with HIV
阻塞性睡眠呼吸暂停的内型及其对艾滋病毒感染者表型的影响
- 批准号:
10155554 - 财政年份:2018
- 资助金额:
$ 33.59万 - 项目类别:
Heroin abstinence induced HPA & SAM dysregulation disrupts HIV virologic control
海洛因戒断诱发 HPA
- 批准号:
8616999 - 财政年份:2014
- 资助金额:
$ 33.59万 - 项目类别:
Heroin abstinence induced HPA & SAM dysregulation disrupts HIV virologic control
海洛因戒断诱发 HPA
- 批准号:
8871706 - 财政年份:2014
- 资助金额:
$ 33.59万 - 项目类别:
CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS RESEARCH (CHARTER) EXTENSION
CNS HIV 抗逆转录病毒治疗效果研究(章程)扩展
- 批准号:
8737536 - 财政年份:2010
- 资助金额:
$ 33.59万 - 项目类别:
CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS RESEARCH (CHARTER) EXTENSION
CNS HIV 抗逆转录病毒治疗效果研究(章程)扩展
- 批准号:
8910507 - 财政年份:2010
- 资助金额:
$ 33.59万 - 项目类别:
CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) as a Resource
CNS HIV 抗逆转录病毒治疗效果研究 (CHARTER) 作为资源
- 批准号:
8163758 - 财政年份:2010
- 资助金额:
$ 33.59万 - 项目类别:
CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) as a Resource
CNS HIV 抗逆转录病毒治疗效果研究 (CHARTER) 作为资源
- 批准号:
8540327 - 财政年份:2010
- 资助金额:
$ 33.59万 - 项目类别:
相似海外基金
RESISTANCE OF HIV-1 TO ANTI-RETROVIRAL AGENTS
HIV-1 对抗逆转录病毒药物的耐药性
- 批准号:
3030975 - 财政年份:1993
- 资助金额:
$ 33.59万 - 项目类别:
POLYMERICS DELIVERY SYSTEMS FOR ANTI-RETROVIRAL AGENTS
抗逆转录病毒药物的聚合物递送系统
- 批准号:
3489187 - 财政年份:1990
- 资助金额:
$ 33.59万 - 项目类别:
DEVELOPMENTAL VIROLOGY RESEARCH--RESISTANCE TO ANTI-RETROVIRAL AGENTS
发育病毒学研究——抗逆转录病毒药物的耐药性
- 批准号:
2335293 - 财政年份:
- 资助金额:
$ 33.59万 - 项目类别: